Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

We are the first Royal Society of Chemistry journal to be gold open access from launch – allowing a global, interdisciplinary network of nanoscale researchers free access to quality, field-advancing ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...